Overview
Michael Ruzicka practices practicing medicine in Munich, Germany.
Mr. Ruzicka is highly rated in 1 condition, according to our data. His clinical expertise encompasses Long Haul COVID, Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, and Severe Acute Respiratory Syndrome (SARS).
He is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Michael Ruzicka
Is Michael Ruzicka a top-rated expert for Long Haul COVID?
MediFind is an objective health platform that identifies experts based on real-world data. Michael Ruzicka is classified as an Advanced expert for Long Haul COVID, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Michael Ruzicka participate in research or clinical trials?
Yes. Michael Ruzicka has published 20 articles and abstracts on conditions like Long Haul COVID. You can view a list of Michael Ruzicka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Long Haul COVIDMr. Ruzicka isAdvanced. Learn about Long Haul COVID.
- Experienced
- Adult Immune ThrombocytopeniaMr. Ruzicka isExperienced. Learn about Adult Immune Thrombocytopenia.
- B-Cell LymphomaMr. Ruzicka isExperienced. Learn about B-Cell Lymphoma.
- COVID-19Mr. Ruzicka isExperienced. Learn about COVID-19.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Ruzicka isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Hemophagocytic LymphohistiocytosisMr. Ruzicka isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- HistiocytosisMr. Ruzicka isExperienced. Learn about Histiocytosis.
- Immune Thrombocytopenic Purpura (ITP)Mr. Ruzicka isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- Non-Hodgkin LymphomaMr. Ruzicka isExperienced. Learn about Non-Hodgkin Lymphoma.
- Non-Langerhans-Cell HistiocytosisMr. Ruzicka isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- PurpuraMr. Ruzicka isExperienced. Learn about Purpura.
- ReticulohistiocytomaMr. Ruzicka isExperienced. Learn about Reticulohistiocytoma.
- Severe Acute Respiratory Syndrome (SARS)Mr. Ruzicka isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).